Pfizer says its experimental coronavirus vaccine more than 90 percent effective in trials

The US government has selected three vaccine candidates to fund their Phase 3 trials through Operation Warp Speed.

Pfizer and BioNTech were granted fast track designation by the FDA for two of the companies’ four vaccine candidates against the coronavirus.